BioPharma Dive - Latest News

FDA’s AI tool ‘Elsa’ is here, and the industry has questions

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's rollout.

Jun 6, 2025 - 14:55
 0
FDA’s AI tool ‘Elsa’ is here, and the industry has questions

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's rollout.

Read More

Tags:

Previous Article

Why Puerto Rico is the smart choice for bioscience reshoring

Next Article

STAT+: A kidney disease showdown, and eye risk linked to GLP-1s

Related Posts

AI tool could help doctors ID breast cancers vulnerable to Enhertu

AI tool could help doctors ID breast cancers vulnerable...

May 22, 2025  0

Genetics is a missing link in kidney disease drug development

Genetics is a missing link in kidney disease drug devel...

Jun 2, 2025  0

Biotech funding plummets as Trump policies unnerve investors: Jefferies

Biotech funding plummets as Trump policies unnerve inve...

Jun 4, 2025  0